Patents Assigned to CancerVax Corporation
  • 35 kD tumor associated protein antigen: uses and methods of detection
    Patent number: 7097846
    Abstract: This invention provides the isolation and characterization of a tumor associated antigen which can be used for immunodiagnosis, immunoprognosis, and therapy of human cancer. The antigen is a protein molecule with a molecular weight of about 35 kD after reduction and separation by SDS-polyacrylamide gel electrophoresis. The antigen has been detected in serum of cancer patients.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: August 29, 2006
    Assignee: CancerVax Corporation
    Inventors: Jan H. Wong, Rishab K. Gupta, Donald L. Morton
  • 35 kD tumor associated protein antigen: uses and methods of detection
    Patent number: 6491926
    Abstract: This invention provides the isolation and characterization of a tumor associated antigen which can be used for immunodiagnosis, immunoprognosis, and therapy of human cancer. The antigen is a protein molecule with a molecular weight of about 35 kD after reduction and separation by SDS-polyacrylamide gel electrophoresis. The antigen has been detected in serum of cancer patients.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: December 10, 2002
    Assignee: Cancervax Corporation
    Inventor: Donald L. Morton